Search
for
Sort by
Research 451–480 of 1000+
- The structure of the cornified claw sheath in the domesticated cat (<i>Felis catus</i>): implications for the claw‐shedding mechanism and the evolution of cornified digital end organs
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Hyperpigmented Upper Eyelid: A Clue to the Diagnosis of Facial Lichen Planus Pigmentosus in a Patient with Frontal Fibrosing Alopecia
- A comment on the post-finasteride syndrome
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Lichen planopilaris caused by wig attachment: A Case of Koebner phenomenon in Frontal Fibrosing Alopecia
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Selection signatures for fiber production in commercial species: A review
- Extracellular Caspase-1 induces hair stem cell migration in wounded and inflamed skin conditions
- Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia
- Frontotemporal hairline recession in a postmenopausal woman
- Lipid nanocosmeceuticals: a novel approach to skin therapy for anti-aging and skin disorders
- Case report: A pregnant woman accidental treated with spironolactone in mid-gestation
- The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- Quality of Life in Men Treated for Androgenetic Alopecia via a Digital Healthcare Platform: A Retrospective Cohort Study
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement
- Exploring the Association Between Multidimensional Dietary Patterns and Non-Scarring Hair Loss Using Mendelian Randomization
- Dynamic immunomodulatory nanoarchitectonics: Rewiring tissue regenerative microenvironment via intelligent regulation
- Pathogenic Mechanisms and Mechanism‐Directed Therapies for Androgenetic Alopecia: Current Understanding and Future Directions
- Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Comment on Current Investigations into the Postfinasteride Syndrome
- A Comment on Coronavirus Disease 2019 and the Hair
- An <i>mTurq2-Col4a1</i> mouse model allows for live visualization of mammalian basement membrane development
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials